Eton Pharmaceuticals (ETON) Research & Development: 2019-2025
Historic Research & Development for Eton Pharmaceuticals (ETON) over the last 7 years, with Sep 2025 value amounting to $1.1 million.
- Eton Pharmaceuticals' Research & Development rose 120.20% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year decrease of 1.14%. This contributed to the annual value of $3.3 million for FY2024, which is 2.02% down from last year.
- According to the latest figures from Q3 2025, Eton Pharmaceuticals' Research & Development is $1.1 million, which was down 70.04% from $3.7 million recorded in Q2 2025.
- Eton Pharmaceuticals' 5-year Research & Development high stood at $3.7 million for Q2 2025, and its period low was -$871,000 during Q4 2024.
- Over the past 3 years, Eton Pharmaceuticals' median Research & Development value was $1.0 million (recorded in 2023), while the average stood at $1.1 million.
- Examining YoY changes over the last 5 years, Eton Pharmaceuticals' Research & Development showed a top increase of 164.00% in 2024 and a maximum decrease of 183.19% in 2024.
- Quarterly analysis of 5 years shows Eton Pharmaceuticals' Research & Development stood at $681,000 in 2021, then surged by 38.62% to $944,000 in 2022, then climbed by 10.91% to $1.0 million in 2023, then slumped by 183.19% to -$871,000 in 2024, then skyrocketed by 120.20% to $1.1 million in 2025.
- Its Research & Development was $1.1 million in Q3 2025, compared to $3.7 million in Q2 2025 and $1.2 million in Q1 2025.